Pharma industry's investments in Finland clearly increased in 2023

Our yearly pharma industry investment survey results have been published.


New Managing Director of PIF is Anne-Mari Virolainen

Anne-Mari Virolainen, M.Sc. (Econ.), has been appointed as the new Managing Director of PIF. Virolainen served as Minister for Foreign Trade and Development in Juha Sipilä's Government from 2018 to 2019. She was a Member of Parliament from 2007 to 2023.


Aunesluoma, Managing Director of Pharma Industry Finland, leaves her position

Sanna Aunesluoma, Managing Director of Pharma Industry Finland (PIF), has resigned from her position to move to a new position outside the Association. Her last day at the Association is April 16, 2024.

08.11.2023 | Petra Tirkkonen, Deputy Managing Director

A competitive Europe brings pharmaceutical industry’s investments and new treatments to patients

The Commission has adopted its proposal for the EU pharmaceutical legislation, which regulates the entire operational environment of the pharmaceutical industry. The objectives of the proposal are commendable, but the means threaten to take Europe in the wrong direction. The Pharma Industry Finland (PIF) would like to thank the Finnish Government, which has highlighted the importance of incentives for research.

20.10.2023 | Camilla Skogman-Lindqvist (Novartis), Outi Lapatto-Reiniluoto (HUS), Mari Sirviö (PIF), Mia Sivén (Helsinki University)

Benefits and challenges of electronic package leaflet (ePL) - review of ePL pilots in hospital settings in Europe

The article has originally been published in European Journal of Pharmaceutical Sciences issue in October 2023.

1 2 3 4 5 6 7